Earnings Estimates

Glossary »

Stock Information

Price (Prev Close) 1,313.00
Price - 52 Week High 1,489.00
Price - 52 Week Low 947.50
Price Date (Latest) Apr 21, 2017
Median Price Target 1,500.00
Diff from Prev Close 187.00
% Difference 14.24%

Reference Information

Last Actual (FY0) 19.22
FY0 End Date Dec '16
Indicated Annual Div. N/A
Hist (5 Yr) Growth % 113.77 %
Hist (5 Yr) Stability % 115.46 %
Yield (%) N/A

 

Analyst Forecasts

Last Month Revisions
Fiscal Period Mean High Low Median # of Estimates # Up # Down Mean % Change
Annual
Dec '19
55.88 90.30 36.57 53.89 11 1 1 -3.49 %
Annual
Dec '18
34.62 45.00 24.80 33.40 11 3 2 -1.51 %
Annual
Dec '17
20.69 23.50 18.10 20.72 12 4 2 5.47 %
Quarterly
Mar '17
-0.19 0.00 -0.37 -0.19 2 0 1 N/A
Quarterly
Jun '17
3.38 3.80 2.97 3.38 2 1 0 -10.92 %
Quarterly
Sep '17
10.23 12.10 8.35 10.23 2 0 1 -15.50 %
Quarterly
Dec '17
6.59 10.97 2.20 6.59 2 1 0 199.32 %
Long Term Growth
N/A
41.61 51.70 22.30 46.00 5 0 1 -  

 

Actuals

Fiscal Period Reported EPS Mean Estimates Surprise % Change
Annual
Dec '16
19.22 15.79 21.70 %
Quarterly
Mar '16
-0.19 0.23 -181.43 %
Quarterly
Jun '16
2.72 1.68 62.32 %
Quarterly
Sep '16
3.06 1.11 175.18 %
Quarterly
Dec '16
13.62 7.36 85.12 %
Annual
Dec '15
12.56 11.26 11.54 %
Annual
Dec '14
5.26 4.05 29.88 %

 

P/E Ratios

Genmab A/S - eafe hea multi-industry

Fiscal Period Genmab A/S eafe hea multi-industry Industry Relative
FY0 58.79 57.39 1.02
FY1 54.62 53.32 1.02
FY2 32.64 31.86 1.02

 

EPS Growth Rates

Genmab A/S - eafe hea multi-industry

Growth Rates Genmab A/S eafe hea multi-industry Industry Relative
FY1/FY0 7.64 7.64 1.00
FY2/FY1 67.32 67.32 1.00
FY3/FY2 61.42 61.42 1.00

Disclaimer: Mean earnings estimates are calculated by First Call based on their earnings projections made by the analysts who cover Genmab A/S. Please note that any opinions, estimates or forecasts regarding Genmab A/S's performance made by these analysts (and therefore the average estimate numbers) are theirs and do not represent opinions, forecasts or predictions of Genmab A/S or its management. Genmab A/S does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

Prices are in DKK